& of course, for those who have the time, I highly recommend reading the full paper, here: doi.org/10.1016/j.ajcn…
But for those who prefer video or TW thread... HERE WE GO...
3/18) What the researchers did in this paper is perform a secondary analysis of pre-existing data from a 12-month RCT: the DIETFITS trial in which 609 adults aged 18-50 without diabetes were randomized to either a 12 m Low-carb diet (LCD) or low-fa diet (LFD).
4/18) Initial data showed LCD led to more weight loss than LFD at 3 and 6 mo, but that the between group diff in weight loss lost significance at 12 months
This was taken to be evidence against the CIM. However, as this paper reveals, there is more nuance to the story...
5/18) One important ? is why significance was lost at 12mo?
2 reasons...
i) Participant dropout. Each group lost ~80 participants, diminishing statistic power
AND
ii) Diet convergence: ‘Carb creep’ in the LCD group (132g/d) + carb drop in the LFD group (213g/d)
6/18) Even setting aside the dietary convergence, when missing data was imputed, the LCD group did in fact lose more weight at 12 m than the LFD group at all time points.
7/18) Moving on, Fig 2 shows a model of predictors of weight loss ➡️ larger circumferences represent better predictors of weight loss
🍽️🍽️Total fat & Calories were poorer predictors of weight loss
🍩🥭Carbs & GI and sugar are the superior predictors
Consistent with the CIM
8/18) In Table are 2 models examining the mediators of weight loss
When you add in Glycemic Load (GL) is added to the model in model 2, GL is highly significant (p=5.7x10-5) and calories (p=0.80) LOSE significance!
Let’s expand on this point...
9/18) Many think that LCD works bc it just makes you eat fewer calories, but that it’s actually the drop in calorie intake that’s driving the weight loss. This certainly is a contributing factor but...
10/18) These results show that GL is better than caloric intake at predicting weight loss, which may appear counterintuitive BUT can be made intuitive if you think about the components of Energy balance: Calories in & Calories out...
11/18) The CICO model, when taken in CLINICAL practice, usually focuses on CI because accurately measuring CO accurately is next to impossible (think, NEAT, TEF, body temp, etc.)
12/18) By contrast, if GL influences the hormonal milieu of the body, it dictates NOT ONLY hunger and caloric intake (CI) but also homeostatic mechanisms to maintain energy equilibrium, or tip it one way or another, through CO: NEAT, body temp, etc.
13/18) Simply put, one could actually make the argument that the CIM is actually a superior real-life ‘CICO’ model than the standard cal counting CICO model itself!
LOL If that doesn’t make sense, read ^ again and watch video for completeness
14/18) Other cool data presented in this paper consistent with the results already shared is that, in fig 5, a biomarker of low-carb/GL (TG/HDL) was strongly associated with weight loss whereas a biomarker of fat reduction (LDL+HDL) was not.
15/18) Finally, and beautifully, the authors put a bold prediction of the CIM to the test which is that those with higher basal insulin secretion would benefit most for GL reduction. Again, this is b/c in the CIM GL influences insulin to cause fat storage.
16/18) So, if someone naturally is an insulin hyper-secreter, the effect of the model is simply going to be amplified. As a result, those who secrete a lot of insulin probably benefit the most from reducing GL. Is that the case? As it turns out yes!
17/18) Clearly see an interaction b/w GL reduction and basal insulin
As you can see in the back left row, these persons who reduced GL most and were the insulin hyper secreters, lost the most weight!
18/18) In summary, this paper provides powerful evidence for two prediction of the CIM: (1) GL > Calories as a predictor of weight loss and (2) insulin hyper secreters benefit most from carb reduction.
1/6) The bile acid and supplement, TUDCA, has the potential to reduce atherosclerosis.
And it appears to do so not by lowering cholesterol, but by reducing inflammation inside arteries. (Red = fatty deposits in arteries)...🔗 in 6/6
2/6) In atherosclerosis, macrophages in the artery wall take up too much oxidized LDL.
This can trigger *ER stress* and activate inflammation, pushing the macrophages into *foam cells* that are a cause and hallmark of atherosclerosis.
3/6) In TUDCA supplementation experiments, TUDCA did not alter total cholesterol or LDL cholesterol levels but led to a significant reduction in arterial fatty deposits in arteries (red staining).
5 Things to Know About Cholesterol-Lowering Drugs 🧵
1/6) Statins are the go-to prescription — but with baggage.
They can:
👉Deplete GLP-1
👉Cause insulin resistance
👉Trigger muscle pain/damage and potentially muscle loss
These risks aren’t often mentioned, but they should be part of a real cost-benefit analysis.
🔗 to the letter at the end, including all hyperlinked references
2/6) Lp(a) and Drug Effects
👉PCSK9 inhibitors = tend to lower Lp(a)
👉Statins = tend to raise Lp(a)
This often-overlooked detail could matter a lot depending on your individual risk profile.
3/6) Ezetimibe blocks cholesterol absorption in the gut — both dietary and recirculated. Liver compensates by increasing LDL receptors.
Its effects are usually modest compared to statins and PCSK9 inhibitors, but if you're low-carb/high-fat you’re naturally recirculating more cholesterol + bile.
Thus, if you’re low-carb, ezetimibe becomes a much more powerful tool for ApoB and LDL lowering.
Creatine Explained: How One Molecule Boosts Muscle and Brain Health 💪🧠🧵
1/11) Creatine is one of the most extensively studied performance-enhancing supplements in the world of exercise science and nutrition.
And yet, despite its popularity, few people truly understand how it works or what its full range of effects might be.
So, let’s break down what you need to know about creatine.
💪Muscle Hypertrophy Mechanisms
💪Brain Health
💪Protocols
2/11) There are several mechanisms through which it can support muscle growth (a.k.a. hypertrophy):
First, Satellite Cell Activation
When muscle fibers grow, they require additional nuclei to manage the increased protein production.
Unlike most cells, which contain only one nucleus, muscle cells are multinucleated. These extra nuclei come from satellite cells—a type of muscle stem cell.
Combined with resistance training, creatine stimulates satellite cell activity, which helps supply growing muscle fibers with the extra nuclei they need to expand.
In simpler terms: creatine makes it easier for your muscles to grow by helping recruit and integrate new cellular “command centers” (nuclei) into the muscle fibers.
3/11) ii. Cell Volumization: Creatine draws water into muscle cells, increasing intracellular hydration.
This “cell swelling” is more than just cosmetic—it acts as a signal that stimulates protein synthesis.
Over time, this contributes to an increase in muscle mass.
Never get Alzheimer’s Disease: The NAD+ Breakthrough
1/9) This graph hints at a potential breakthrough in Alzheimer’s disease.
It shows that NAD+, a key energy carrier in the brain, is depleted in Alzheimer’s—but preserved in cognitively healthy brains.
Restoring it may not just protect memory—it might reverse dementia.
2/9) What is NAD+? NAD+ is an essential energy carrying molecule in the brain.
Most major energy metabolism pathways (carb burning via glycolysis, fat burning via beta oxidation, TCA/Kreb cycle, mitochondrial metabolism) rely on NAD.
When NAD drops, the brain fails.
3/9) In Alzheimer’s, NAD+ levels don’t just drop—they correlate with a core Alzheimer’s biomarker: phospho-tau.
Even more intriguing: some people have Alzheimer’s pathology (amyloid)… but if their NAD+ is high, they don’t tend to develop dementia.
This suggest NAD+ could be a resilience factor in the aging brain… So… what happens if you restore NAD+?
1/4) Why can some people say no to dessert, while others feel pulled toward sugar like it's a black hole?
It's NOT a failure of willpower.
🦷But before we start, tell me: do you have a sweet tooth? What's your dietary Achilles' heel?
2/4) Human data show that levels of a nutrient sensor, FFAR4, are reduced in diabetes, are negatively associated with fasting blood sugar, and are even linked to metabolic health in mendelian randomization studies.
3/4) The researchers dissect a fascinating cascade whereby this nutrient sensor alters the microbiome to change GLP-1 and FGF-21 signaling to alter brain signaling and sugar cravings.
Sugar cravings aren't about willpower. THey're about metabolism.
1/9) New study finds that high Lp(a) increases the risk of death from CVD by as much as 230%.
Since Lp(a) is thought to be genetically determined, some people think if you have high Lp(a), you’re screwed.
🚨But I don’t think so...
2/9) The researchers studied 1,027 patients with advanced coronary artery disease who were undergoing cardiac surgery.
The conventional view is that Lp(a) and related molecules promote atherosclerosis by physically sticking to the artery wall, infiltrating it, and essentially “seeding” plaque.
But there’s more to the story…
3/9) The researchers found that patients with higher Lp(a) also had higher levels of a molecule called “superoxide” (O2×).
And no, despite the name, it’s not Superman of the molecular world. It’s not a hero—it’s a villain.
O2× is a reactive oxygen species. It fuels oxidative stress and inflammation—core pathologies that can drive atherosclerosis.